De Novo device
Modified Trevo ProVue Retriever
Concentric Medical, Inc. · Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL, Class II) · First FDA decision Sep 2, 2016, newest Sep 2, 2016Acute ischemic stroke
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
0
Naming "Modified Trevo ProVue"
MAUDE reports
0
Brand "Modified Trevo ProVue", since 2015
PubMed studies
0
Mentioning "Modified Trevo ProVue"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Modified Trevo ProVue Retriever
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Modified Trevo ProVue Retriever, Trevo XP ProVue Retriever 4x20mm, Trevo XP ProVue Retriever 3x20mm, Trevo XP ProVue Retriever 6x25mm, Trevo XP ProVue Retriever 4x30mmNew device typeDe Novo
DEN150049 · Decided Sep 2, 2016 · 312 days after receipt
Device type: Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Modified Trevo ProVue", any status and sponsor, newest update first.
No registered device study names "Modified Trevo ProVue".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Modified Trevo ProVue", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POL
97 reports: 40 malfunction, 55 injury, 2 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Modified Trevo ProVue"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code POL.
- Trevo NXT ProVue RetrieverStryker Neurovascular · 510(k) 2023
- Trevo NXT ProVue RetrieverStryker · 510(k) 2020
- Solitaire 2 Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2019
- pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy DevicePhenox Limited · 510(k) 2025
- pRESET LITE Thrombectomy DevicePhenox Limited · 510(k) 2023
- pRESET Thrombectomy DevicePhenox Limited · 510(k) 2023
- Solitaire X Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2021
- Trevo XP ProVue Retriever and Trevo NXT ProVue RetrieverStryker Neurovascular · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.